Abstract
Training of neuropathologists varies worldwide. Systems range from highly organized specialist and subspecialist education with national certification, to regulated training with diploma recognition, to informal apprenticeships in neurological hospitals and no formal recognition. This overview compiles and summarizes the history of regulated training systems, the status of neuropathology within various countries' medical systems and the manner in which neuropathologists are trained. Anecdotal evidence suggests that countries with regulated systems of neuropathology training and an active professional organization are more likely to have an adequate supply of diagnostic specialists and a vibrant research community. The different training systems reflect the style of medical services delivery in the respective countries. In general, the existence of formal neuropathology training systems occurs only in countries with relatively high levels of per capita health expenditures, reflecting the development of medical specialization overall. Evolving diagnostic technologies and major international research endeavors, whose goals are to understand structure and function of the human brain, demand that neuropathology training is more than simply diagnostic histopathology.
Keywords: history, medical education, medical specialization, pathology
Introduction
Enormous effort goes into the scientific investigation of neurological diseases and dissemination of the findings so that the information might eventually be used to improve the understanding of disease and the health of humans. Major international research initiatives are being developed to understand the workings of the human brain, one desired outcome of which will be the ability to diagnose brain disease earlier so that treatments can be started before the occurrence of irreversible damage. Within the new European Union (EU) program Horizon 2020, the Human Brain Project was selected in 2012 as one of two flagship research programs 73. In the United States (US), the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative was announced in 2013 53. Detailed examinations of human brains and accurate disease diagnoses are required to develop and utilize the anticipated information. Currently, the definitive diagnosis of many neurological diseases remains dependent on direct examination of tissues obtained by biopsy or at autopsy. Hence, there is a worldwide need for well‐trained neuropathologists capable of making these diagnoses and communicating the findings in wording that can be widely understood (with inter‐language translation if necessary). The purpose of this manuscript is to compare and contrast the modalities used for training neuropathologists in countries with formalized training systems. Specific competencies that should be acquired by neuropathologists‐in‐training are not considered here.
Historical Background
An understanding of the current training of neuropathologists requires some appreciation of relevant history 49, 99. Neuropathology (NP) is the medical discipline concerned with the evaluation of tissues (and cerebrospinal fluid) for diagnosis and understanding pathogenesis of diseases of the central nervous system and its coverings, the peripheral nervous system, and the skeletal muscle. Following Rudolf Virchow's pioneering concepts of cellular pathology 95, 104, 113, the academic pursuit of NP in the late 19th century arose mainly from the desire of neurologists and psychiatrists to better understand diseases of their patients 41. These pursuits were facilitated by the application of rapidly evolving neuroanatomical staining techniques [eg, Santiago Ramon y Cajal and others 46, 76 ]. Special institutions dedicated to the study of the physiology, anatomy and pathology of the nervous system were founded in the late 19th century, first in Vienna (by Heinrich Obersteiner) and subsequently in other European centers, in the US, and in Japan. In the late 19th and early 20th centuries, more focused study of NP evolved rapidly particularly in Germany, Switzerland and Austria, as well as in England and France 3, 50, 99.
During the early 20th century, NP training was an informal apprenticeship structured largely by the (often multidisciplinary) interests of the trainee. Harvey Cushing and Wilder Penfield, both renowned neurosurgeons, were disciples of the renowned pathologist William Osler 33. Following training in a range of disciplines, Cushing along with Percival Bailey (also principally a neurosurgeon) devised the first histopathologic classification of brain tumors in 1926 10, 81, while Penfield edited the first multiauthor textbook on NP in 1932 25.
In the mid‐20th century, with the advancement of medical knowledge and technologies NP became less and less a hobby of neurological clinicians. As the infrastructure needs (eg, tissue processing, autopsy facilities, microscopy) of neuropathologists converged with those of other pathology disciplines there was a tendency for practitioners to be housed together. In general, medical training was becoming more structured with the creation of oversight organizations. These forces gradually led to formalization of NP training, the structure of which differed considerably worldwide. The purposes of this manuscript are to describe the various systems for training neuropathologists worldwide, to identify common themes and challenges, and to suggest future needs.
Methods
In 2011, the lead author began acquiring information and documents from government and medical organizations responsible for the oversight of specialty medical training, and specifically NP training, worldwide; this information was revalidated in 2013. Published historical information concerning the development of NP was sought through structured searches of PubMed and GoogleScholar online databases. Simultaneously, individuals identified as leaders in their respective countries were contacted (the Society News section published in each issue of Brain Pathology and the website of the International Society for NP was one source for this information). Important factors in the training of neuropathologists were identified through in‐person and e‐mail discussions. A good resource for comparing general aspects of postgraduate medical education is the website of the Foundation for Advancement of International Medical Education and Research (FAIMER), Postgraduate Medical Education (PME) Project (http://www.faimer.org/resources/pme/index.html).
NP training as a primary medical specialty
Six countries [Austria, Canada, Germany, Ireland, Switzerland and United Kingdom (UK)] recognize NP as a primary specialty, that is, a discipline of medicine sufficiently distinct that medical school graduates can enter the training programs directly. In these jurisdictions, highly structured paths of training are mandated and monitored by national organizations, most incorporating some form of competency‐based training followed by standardized examination and mandatory continuing education after certification. The countries are considered in the temporal sequence that specialty recognition was achieved because some of the historical details and guidelines of training are similar (Table 1).
Table 1.
Comparison of training to become neuropathologist in various national jurisdictions (data for 2013). Abbreviations: NP = neuropathology; RCPSC = Royal College of Physicians and Surgeons of Canada; FMH = Fédération des Médicins Helvetica; SIWF = Schweizerisches Institut für ärztliche Weiter‐und Fortbildung; ISFM = Institut Suisse pour la formation médicale postgraduée et continue; Euro‐CNS = European Confederation of Neuropathological Societies; AP = anatomical pathology; ACGME = Accreditation Council for Graduate Medical Education; CMKP = Center of Postgraduate Medical Education; GP = general pathology; N/A = not applicable
Country | Population (millions)a | Annual health expenditure per capitab | Status of neuropathology disciplinec | Total years of training (years of NP training)d | Clinical neurosciences | Number of training sites | Written exam | Practical exam | Language | Oversight organization | Professional society (year established) |
---|---|---|---|---|---|---|---|---|---|---|---|
Canada | 34 | 5200 | Specialty (since 1965) | 5 (3) | Yes (6 months in first year) | 5 | Yes | Yes | English/French | RCPSC | Canadian Association of Neuropathologists (1960) |
Germany | 82 | 4700 | Specialty (since 1985) | 6 (4) | Optional | 27 | Yes | Oral | German | German Medical Association | German Society of Neuropathology and Neuroanatomy (1950) |
Austria | 8 | 5000 | Specialty (since 1994) | 6 (4) | Yes | 3 | Yes | Oral | German | Austrian Medical Chamber | Austrian Society of Neuropathology (1956) |
Ireland | 5 | 4200 | Specialty (since 2005) | 5 (3) | Optional in final year | 2 | Yes | Yes | English | The Irish Medical Council, through the Royal College of Physicians in Ireland and the National Training Body for Histopathology and Neuropathology | Irish Neuropathological Association (1997) |
Switzerland | 8 | 7800 | Specialty (since 2007) | 5 (3) | Optional | 3 | Yes | Yes | German/French | FMH/SIWF/ISFM | Swiss Society of Neuropathology |
United Kingdom | 63 | 3500 | Specialty (since 2011) | 6 (4) | Yes | 12 | Yes | Yes | English | The General Medical Council, through the Royal College of Pathologists and Lead Dean for Histopathology and Neuropathology | British Neuropathological Society (1950) |
European Union | 504 | 3400 | European Fellow in Neuropathology exam | 5 (3) | Yes | Yes | Yes | Euro‐CNS | Euro‐CNS (1993) | ||
United States | 312 | 8400 | Subspecialty of AP (certification with exam since 1948) | 4–6 (2) | No | 35 | Yes | Yes | English | ACGME oversees training; the American Board of Pathology oversees the examination and certification | American Association of Neuropathologists (1930) |
Finland | 5 | 3900 | Subspecialty of Pathology | 7 (2) | No | N/A | Yes | Yes | Finnish | Ministry of Education | Scandinavian Neuropathological Society (1965) |
France | 65 | 4700 | Subspecialty of Anatomical Pathology or Neurology (Diploma with exam) | 6 (2) | Yes | 16 | Yes | French | Ministry of Health | Société Française de Neuropathologie (1965) | |
Poland | 38 | 900 | Subspecialty of Pathology, Neurology or Neurosurgery | 8 (3) | Yes | 2 | Yes | Yes | Polish | CMKP | Polish Association of Neuropathologists (1964) |
Australia / New Zealand | 27 | 4700 | Subspecialty of AP GP | 6 (1) | No | 5 | Yes | Yes | English | Royal College of Pathologists of Australasia | Australian and New Zealand Society for Neuropathology (1979) |
India | 1241 | 50 | Subspecialty of AP (Post Doctoral Certificate Course) | 3–4 (1) | 1 | Indian College of Pathologists | |||||
Japan | 128 | 4100 | Subspecialty of AP, Neurology, Neurosurgery—no formal recognition | Variable after primary specialty | Japanese Society of Neuropathology (1966) | ||||||
China | 1344 | 200 | Subspecialty of AP—no formal recognition | Variable after primary specialty | Neuropathology Groups in the Neurology and Pathology Societies of the Chinese Medical Association | ||||||
Brazil | 197 | 1000 | Subspecialty of AP—no formal recognition | 4–6 (1–3) informal apprenticeship | Sociedade Brasileira de Patologia | ||||||
Russia | 142 | 500 | Subspecialty of AP—no formal recognition | 2 years of “ordinatura” and 3 years of PhD research studies |
Population data reported for 2011 by the World Bank (see http://www.worldbank.org/).
Health expense data reported (in $US, rounded to nearest $100) for 2010 by the World Bank (see http://www.worldbank.org/).
Specialty denotes a free‐standing discipline in which training can be started directly following medical school. Subspecialty denotes a discipline that depends on primary certification in another discipline, typically AP or clinical/general pathology, or less often neurology.
The total years denotes the minimum duration of training including, for example, general medicine, clinical neurosciences, anatomical/surgical pathology or general/clinical pathology, and NP.
Canada
The history of NP in Canada was described in detail in a recent publication 25. The Royal College of Physicians and Surgeons of Canada (RCPSC) was founded in 1929 to oversee postgraduate medical education. In 1946, certification in General Pathology was formally recognized. Beginning in 1960, the Canadian Association of Neuropathologists (CANP) began lobbying the RCPSC for recognition of NP as a primary specialty. The CANP argued that the knowledge base was distinct from that of general or anatomical (surgical) pathology and that comprehensive clinical skills could only be obtained through several years of focused training. In 1965, the RCPSC introduced eligibility for certification in NP with 5 years of training after medical school. Alternate training paths were an additional 2–3 years of training in NP after certification in pathology. Training sites were eligible only if they also had a residency‐training program in anatomical pathology (AP) and there were stipulations on minimum number of autopsy and surgical cases; the guiding document was <2 pages length. The first Canadian certifying examination in the specialty of NP was administered in 1968 25. Training requirements evolved gradually. The mandatory 6‐month rotation in clinical neurology became optional in 1975. In 1976, a specialty committee on NP was established within the RCPSC to oversee training details. The oral examination was replaced by a practical examination in 1984. In the mid‐1990s, the RCPSC began to consider core training in Laboratory Medicine but the concept was eventually discarded 102. Clinical neuroscience training was reestablished as mandatory in 1997. Practical oversight of residency programs in Canada was modified considerably with the 2000 introduction of CanMEDS, a framework of competencies organized around seven physician roles 38. Although the philosophical principles were accepted as sound, there were concerns about the work required for documentation and the difficulty teaching and assessing some of the competencies. The most serious threat to NP training in Canada was yet to come. In response to political and administrative pressures, combined with the perception that NP was not recognized as specialty elsewhere 124, in 2003 the RCPSC converted NP to a subspecialty of AP, effectively increasing the mandatory training period to 7 years. Until 2008, when the decision was overturned, not a single Canadian medical school graduate began NP training in Canada. During this period, two of the seven approved training centers closed 25. Following restoration of NP's specialty status, vitality returned to the system. In 2012, the RCPSC Committee on Specialties concluded that NP was functioning well as a specialty. Currently, training consists of 1‐year clinical service including 6 months of neurosciences, 1 year of AP (autopsy, cytology, surgical pathology) and 3 years of core NP including elective periods. Following completion of training, candidates are eligible to write the 2‐day examination, which consists of short answer and multiple‐choice questions and practical material (glass slides and images including digital microscopy). It is likely that a structured oral examination component will be reinstituted in 2015. CanMEDS guidelines will be revised in 2015 and training milestones will be introduced in the following few years.
Germany
It can be argued that the roots of modern pathology arose in German‐speaking European countries 26. The rich history of NP in Germany is well documented 6, 94. The Vereinigung Deutscher Neuropathologen (Association of German Neuropathologists) was founded in 1950 114. This group initially advocated for the integration of NP into pathology institutes, in part to avoid isolation from other pathology specialties 7. In 1975, the association was renamed as Deutsche Gesellschaft für Neuropathologie und Neuroanatomie (DGNN—German Society of Neuropathology and Neuroanatomy). There are currently 21 independent university departments of NP in Germany as well as six divisions of NP associated with departments of pathology. Oversight of medical specialty training is through the Bundesärztekammer (German Medical Chamber) and the specific guidelines for training neuropathologists are created by the Qualification and Training Committee of the DGNN and passed by the DGNN general assembly. Beginning in 1966, representatives of the DGNN began lobbying for a specialist route of training. Initial proposals included the possibility of entering NP by way of neurology or psychiatry 94. In 1976, the Bundesärztekammer introduced a framework of NP training as a subspecialty of pathology, which included 3 years in pathology and 2 years in NP. Subsequently, the NP community sought to define NP as a discipline in its own right 93. After years of opposition from the German Society of Pathology and with the support of the German Societies of Neurosurgery and Neurology, NP achieved primary specialty recognition in 1985 106. The current training curriculum includes 2 years of training in a “common trunk” that includes pathology and 4 years of training in NP of which up to 1 year can be neurosurgery, neurology, pediatric neurology, neuroradiology and/or psychiatry. In 2012, the Bundesärztekammer officially adopted a modification of the CanMEDS framework as a template for defining postgraduate training competencies 13.
Austria
The clinical neurosciences as an interaction between psychiatry, neurology, pathology and anatomy/physiology began to develop in Austria during the late 18th century 55, 109. The Institute of Neurology was founded in Vienna in 1882 by the neurologist Heinrich Obersteiner as the world's first interdisciplinary university institution exclusively dedicated to the investigation of structure, function and diseases of the human nervous system 55, 64. Franz Seitelberger, a neurologist and neuropathologist, oversaw considerable postwar rebuilding as director from 1959 to 1987. In 1961, he was the founding editor of the international journal, Acta Neuropathologica 56. The Austrian Association of Neuropathology was organized in 1956 108. Leaders in the community believed that the best way to ensure quality of the diagnostic discipline was to train individuals as primary specialists with some degree of independence from pathology. NP thereby was an equal partner with neurology and neurosurgery in the development of interdisciplinary clinical neuroscience centers at the medical universities. The Austrian Medical Chamber enacted specialty training guidelines in 1994. Current minimum training requirements consist of 6 months in histopathology, 18 months in clinical neuroscience and 4 years in diagnostic NP. At the end of the competence‐based (knowledge, skills, experience) training curriculum, candidates are assessed by means of structured oral exam and a practical slide exam. A committee of three examiners is nominated from the Austrian Medical Chamber. As elsewhere, competency‐based training concepts are evolving. A new modular system that comprises a core module of basic competences and additional optional modules of special competences (eg, clinical neurochemistry) will be implemented within the next years. Currently, there are three training sites (Vienna, Graz, Linz) with the mandated minimum of two board certified specialists. Only the largest center in Vienna has the capacity to teach all aspects of diagnostic NP; it furthermore houses central referral laboratories that focus on neurochemical, molecular and genetic aspects of neurologic disease as well as large brain and tissue bank for teaching and research purposes (eg, MedUni Vienna neurobiobank).
Ireland
Through the Faculty of Pathology and the Irish Committee on Higher Medical Training (ICHMT; Royal College of Physicians of Ireland), NP training has been offered as a specialty since 2005. Two years of Basic Specialist Training (BST) in histopathology is the first step followed by a 3‐year competency‐based curriculum in NP at the Higher Specialist Training (HST) level. The community of neuropathologists in Ireland is small with training programs in two cities (Dublin, Cork) (Michael Farrell, pers. comm.).
Switzerland
Following the lead of Germany and Austria, neuropathologists in Switzerland began to advocate for specialty recognition in the 1990s. The goals were to protect those who entered the training, and to increase the interest in diagnostic NP. In 2007, the Fédération des Médicins Helvetica (FMH) officially launched NP training programs in Zurich, Basel and Geneva. Other locations are being considered (Elisabeth Rushing and Adriano Aguzzi, pers. comm.). The training consists of 3 years of clinical NP, 1 year of clinical pathology and 1 year of another clinical neuroscience or research. The training guidelines have adopted CanMEDS principles.
UK
The history of NP in the UK is well documented 3, 40, 112. Organization of medical services under the National Health Service Act of 1947 led to the establishment of specialty posts in NP at large centers in the UK, typically focused on a neurosurgical service 78. The regional centers provided a framework for the clinical services, as well as for teaching, training and research 3. In 1950, J. Godwin Greenfield established the Neuropathological Club, which in 1962 came to be known as the British Neuropathological Society 3, 40. In the same year, the College of Pathologists was founded. Some individuals, including the neuropathologist William McMenemey, argued against the formation of a separate college of pathologists, citing the dangers of a fragmented medical profession and the homogenization of NP training 79 77. The College, which received Royal Charter in 1970, has responsibility for training curricula and assessments in histopathology and other laboratory specialties 118, 123. One of the consequences was the specific alignment of NP as a subspecialty of histopathology and abandonment of neurology as an entry point.
In a 1967 survey, Marion Smith identified a shortage of neuropathologists in Great Britain. She attributed this in part to the protracted training duration, with 5 years of general pathology mandated prior to an additional 2–3 years of NP training. She also noted that a lack of clinical neurology was “the most frequent regret as to a deficiency in their own training,” particularly in relation to neurological postmortem studies 111. Concern about the training of neuropathologists persisted for decades. In 2001, Jennian Geddes wrote “the demands of modern training curricula now make it difficult for those without a background in general pathology to enter the specialty. This is likely to favour the assimilation of clinical NP into general pathology in the UK, with the neuropathologist inevitably being replaced by a general pathologist ‘with an interest in’ NP at some centres” 40. In June 2004, the Royal College of Pathologists and Department of Health (England) launched a scheme to help ameliorate the consultant workforce crisis in NP; this would allow selected histopathologists to undertake a “Conversion Fellowship” of abbreviated education and training. Consensus was finally reached that the conduct of NP training as a subspecialty of histopathology was no longer tenable. In 2010, the Royal College of Pathologists and the British Neuropathological Society jointly submitted an application to the Department of Health requesting establishment of a specialty in Diagnostic Neuropathology. The arguments for this change were very similar to those used successfully in Canada and Germany (eg, NP has its own defined competences; the lengthy two‐step training deters applicants and is wasteful; specialty status would allow entry of trainees from neurology and neurosurgery; NP is an emerging parent to new subspecialties). In 2011, NP was granted specialty status. The minimum training requirements are 1 year in histopathology, 1 year in clinical neuroscience and 3 years in diagnostic NP. This is essentially identical to the curriculum in Canada. Candidates are eligible to write the Euro‐CNS (European Confederation of Neuropathological Societies) examination (see below). Staged competences, outlined using standards of the then Postgraduate Medical Education and Training Board (PMETB), now subsumed within the General Medical Council (GMC), are defined in the training documents (http://www.gmc‐uk.org/Curriculum_Diagnostic_Neuropathology.pdf_51121493.pdf).
EU
The European Union of Medical Specialists (UEMS) was founded in 1958 to deal with various matters including quality of specialty training. Pathology, which was broadly defined in 1962, was divided in 1988 into separate sections including anatomic pathology. The European Board of Pathology (EBP) was established in 1992, followed by the European Association of Pathology Chairs and Residency Programme Directors in 2005. Committees have been created to address harmonization of training, to establish general and specialty‐specific competencies, to assess the feasibility of European exit examinations, and to examine the conflict between general and subspecialty competencies in pathology 103, 125. The EBP has acknowledged that the regulatory status of NP differs between countries (ie, specialty vs. subspecialty). In 2011, the EBP agreed upon requirements for a 5‐year postgraduate pathology‐training curriculum, with a 3‐ to 4‐year trunk leading to subspecialization 120. Alarmingly, the architects wrote, “Training in so‐called areas of interests [including neuropathology] can cover the remaining 12–24 months” and “Following this structure, isolated specialization in parts of pathology such as … neuropathology (UK) can be avoided” 119. We must emphasize that these statements reflect the view of general pathologists who are concerned about the integrity of their discipline, but not the view of European neuropathologists and clinical neuroscientists.
The Euro‐CNS was established in 1993 to facilitate the development and harmonization of NP across the EU. In 2006, Mikol and Weller reviewed the status of NP in European countries 83. They reported that this ranged from an officially recognized specialty or subspecialty, to the absence of official recognition. In their consideration of challenges, they advised renewed efforts to gain official recognition for NP “in as many countries as possible,” following the 2004 rejection of specialty status by the UEMS EBP. Their publication documents some of the political aspects of this struggle and the importance of attracting trainees with backgrounds in clinical neurosciences. The curriculum for the European Fellowship in Neuropathology (EFN), adopted in 2011, is a modification of that used for the recently approved specialty training in NP developed in the UK (see http://www.euro‐cns.org/examefn/examination/). Eligibility for the examination includes 5 years of supervised training including 1 year in histopathology, 1 year in clinical neuroscience (clinical neurology or neurosurgery, either adult or pediatric), and 3 years in diagnostic NP, as well as documented experience with a specified minimum number of autopsy brains and spinal cords, neurosurgical biopsy specimens, skeletal muscle biopsies, peripheral nerve biopsies and cerebrospinal fluid cytological preparations. Note that this is essentially the same as the national requirements where NP is recognized as a specialty, although need for enumeration of cases is not unanimous. Although Euro‐CNS guidelines do not override member country regulations, ultimately this broad agreement overcomes some of the problems seen in neurology training, wherein there is considerable variation across Europe 115. Euro‐CNS has also established a set of continuing medical education courses that cover many areas of NP and are designed to enhance training and raise standards in NP.
NP training as a medical subspecialty
Many countries officially recognize NP as a subspecialty, usually of AP (histopathology) and less often of neurology or neurosurgery. In this circumstance, training (and usually certification) in the primary specialty must precede structured training in NP. Several populous countries and many smaller countries generally consider NP to be a subspecialty of AP, but do not formally recognize its status and lack structured training programs (Table 1).
US
Although not the birthplace of NP, the US has become the most prolific breeding ground for neuropathologists. The Neuropathology Club, a group for sharing interesting cases, started in 1925 and it gave rise to the American Association of Neuropathologists (AANP), which was founded in 1930 48, 49. In the US, NP training is a mandatory subspecialty of AP. The American Board of Pathology (ABP), a branch of the American Board of Medical Specialties (ABMS), was established in 1936 and is responsible for evaluation and certification of pathologists. ABP certification examinations in NP began in 1948 30. According to Harry Zimmerman, in the 1950s NP training efforts were often lost on people who subsequently became neurologists or neurosurgeons. He and others decided that the best way to ensure a lasting commitment to NP was to demand prior training in laboratory medicine; they did not view this as a divorce from the clinical neurosciences 136. Abner Wolf wrote in 1954, “neuropathology is a branch of general pathology and should be rooted in it,” although he did not think that complete general pathology training was necessary because of the time needed 131. Lester King suggested that 3–6 months of study in the basic neurosciences during a general pathology residency was sufficient 62. Nevertheless, for decades some leaders of the NP community including Armando Ferraro 34 expressed continued opposition to the separation of NP from neurology and psychiatry. In 1964, Orville Bailey advocated for a background in clinical neurology and general pathology with “at least two years of special training in neuropathology” 9. Martin Netsky wrote in 1965, “It is unfortunate that the American Board of Pathology, although a relatively enlightened group among the certifiers, has taken on itself the accreditation of neuropathologists, because they represent their specialty, and not neurology or the combined field” 85. Because of the practical impossibility of fully staffing all centers with neuropathologists, Kepes and Burger advocated for a balance, “the general pathologist takes part in diagnosing neuropathologic specimens, particularly where no neuropathologist is available … neuropathologists will, and should, remain in the forefront of perfecting diagnostic procedures and advancing knowledge in neuropathology” 61.
Training of neuropathologists in the US remained for some time a very local issue. In 1964, there were 16 programs that offered 1–4 years of training, mainly to individuals from pathology backgrounds 132. When Netsky surveyed nine training programs in 1976, he observed “an enormous diversity of methods used to achieve a common goal—the training of a neuropathologist.” He was concerned that the “lack of knowledge of clinical [neurological] problems is a defect in the training of some neuropathologists.” At that time, the programs expected 1–2 years of training in general pathology plus 2 years in neuropathology. Seven directors opined that trainees should be “able to take an examination in neuropathology alone” 86. Unification of agencies responsible for graduate medical education began in 1972 and the Accreditation Council for Graduate Medical Education (ACGME) was created in 1981. This led to standardization of training requirements across the country. Currently, 4‐year AP/NP (2 years each) programs are most commonly offered, with eligibility for the NP examination only after certification in AP. Other options include: (i) a 3‐year AP residency with a subsequent 2‐year NP fellowship; (ii) a triple fellowship in AP, clinical pathology and NP (2 years each); or (iii) entry from neurology or neurosurgery with 1 year of supplemental training in AP and 2 years in NP 4. Hence, NP training in the US can take 4–6 years. Training requirements are in accordance with the competencies defined by the ACGME, which also provides oversight of training. Certification and examination are governed by the ABP. With respect to organ‐related competencies, there is a greater expectation of knowledge about ophthalmic pathology than in most other countries. The current challenge for the providers of NP training in the US is refinement of the assessment tools to include specific milestone indicators within the competencies.
Poland
Foundations for the development of the discipline of NP in Poland were laid with the establishment of the Department of Neuropathology in the Polish Academy of Sciences in 1954. In 1964, the Polish Association of Neuropathologists (PANP) was founded and the periodical journal, Neuropatologia Polska (now Folia Neuropathologica), was launched 90. The PANP lobbied the Medical Centre of Postgraduate Education, and in 1973 NP became a separate medical subspecialty, followed in 1976 with a change in status to second‐grade specialty. NP remains a subspecialty that a trainee may begin only after 5 years of training in general pathology, neurology or neurosurgery. The Center of Postgraduate Medical Education (CMKP) approved a 3‐year NP curriculum in 2004. Accredited training occurs at two of the four academic centers with NP activities. Training culminates in a final written, oral and practical examination. At least two neuropathologists are needed to have an accredited training site. The lengthy training duration has been a major hindrance to recruitment of trainees, consequently Poland is lacking in subspecialty areas like muscle pathology. Plans are underway to convert NP to a specialty with a 5‐year training program; however, there are concerns about the earning potential of fully specialized neuropathologists.
France
Critical developments in the clinical neurosciences occurred in France in the 1800s to mid‐1900s under the leadership of luminaries such as Jean‐Martin Charcot and Paul Broca 15, 16. Perhaps in part because of the preeminent status of clinical neurology, diagnostic NP has been institutionalized under AP since the 1950s 18. NP is recognized as a subspecialty in France. Following residency training in AP or neurology, the Société Française de Neuropathologie (SFNP) offers educational opportunities leading to the Diplôme d'études spécialisées complémentaires (DESC). This course, approved in 2002 by the Ministries of Health and Education, includes 2 years of didactic and practical training followed by written and practical examination. The diploma alone does not allow one to practice NP; this must take place within a pathology department (Charles Duyckaerts, pers. comm.).
Italy
The history of NP research in Italy mirrors that in other European countries, but NP only became distinguished as diagnostic discipline in the 1980s 105. The Italian Association of Neuropathology (now known as the Italian Association of Neuropathology and Clinical Neurobiology) was established in 1966 and the need to develop “neuropathology specialty schools” was identified by Macchi in 1981 72. Within research domains, the discipline of NP is important, and centralized diagnostic laboratories are well established within neurological clinics. However, because NP is not recognized as a distinct clinical specialty, it has negligible profile in the undergraduate medical curriculum and diagnostic neuropathologists have become fewer (Marina Melone, pers. comm.).
Spain
Despite being the homeland of among the most famous neurohistologists (eg, Santiago Ramon y Cajal, Pio del Rio Hortega), NP is not officially recognized as even a subspecialty in Spain. Specialty training in Pathologic Anatomy includes some teaching in tumor NP during the 4‐year program. The full spectrum of NP is practiced in Spain by individuals who train at regional specialty centers (eg, in Madrid and Barcelona) or abroad. New trainees are encouraged to get certification through the Euro‐CNS examination process (Isidro Ferrer, pers. comm.).
Scandinavia
In Finland, pathology residency is 5 years followed by a national certification examination. NP is considered a subspecialty, which requires 2 years of training under guidance of a senior pathologist. At least three Euro‐CNS courses must be attended and there is a national exam at the end of the training (Maria Gardberg, pers. comm.). NP is not officially recognized as a subspecialty in Sweden, Norway or Denmark. Trainees undertake informal apprenticeships with senior neuropathologists supplemented by Euro‐CNS courses (Eva Løbner Lund, pers. comm.).
Russia
In Russia, the term “neuropathologist” describes physicians who elsewhere are called neurologists. The term “neuromorphologist” may include pathologists who study the nervous system or anatomical researchers 66. Pathology training consists of a 2‐year “ordinatura” regulated by the Ministry of Health. Some have declared that the training is of inconsistent quality and in need of standardization 54, 137. Research‐oriented neuroscience training may follow the ordinatura, but NP is not a formally recognized specialty and only a small number of medical institutes in Russia have individuals working primarily in NP (Andrey Korshunov, pers. comm.).
Australia and New Zealand
Oliver Latham established a NP laboratory in Sydney in 1908, and his work provided the foundations for NP in Australia 37, 51. However, there was little collaboration between neurosurgeons and pathologists for decades 110 and there was no formal training program. In 1973, the shortage of neuropathologists in Australia was lamented; it was suggested that the resistance lay with the general pathologists 27, 28. The Royal College of Pathologists of Australasia (RCPA) has been responsible for the training oversight and professional development of pathologists since 1956. In 1979, during the Annual Meeting of the RCPA, pathologists interested in NP formed the Australian and New Zealand Society for Neuropathology (ANZSNP). During the 1990s, the RCPA ran a subspecialty option where training in NP was taken in addition to AP, extending the training program from 5 to 6 years. There is an expectation that all AP fellows can diagnose brain tumors, vasculitis, basic neurodegenerative diseases and basic muscle pathology. The RCPA had adopted Core CanMEDS objectives for AP; however, a modified competency structure was created in 2010. In the same year, the RCPA formalized a 1‐year post‐Fellowship Diploma in Neuropathology (Dip. Neuropath) for fellows who have completed a 5‐year fellowship in AP, forensic pathology or general pathology. The additional training concentrates on more advanced and rare brain, nerve, and muscle disorders. Assessment includes a submitted portfolio, a structured oral examination and a practical slide examination. In practice, the portfolio requirements, which are based on the UK requirements, typically take 1–2 years or more to fulfill. Some in the community have expressed interest in establishing specialty level training 31; however, the vast majority favors the current system because it already meets stringent guidelines and because there are very few pure NP positions funded by the Australian state governments.
Japan
Japan adopted a German‐style medical system in the mid‐1800s and until the 1950s psychiatrists drove most neuropathological research, after which time NP began to converge with histopathology. The Japanese Society of Neuropathology (JSN) was established in 1966 74. This vibrant research society has over 1200 members. Postgraduate medical education in Japan was reformed extensively in 2004 {Teo, 2007 #19696}. The Japanese Board of Medical Specialties oversees medical specialty residencies including a 5‐year course of training in AP, which leads to board certification by the Japanese Society of Pathology 63, 89. However, there is no specific residency or certification for clinical NP and consequently it is difficult to train young neuropathologists. Although many train in other countries, especially the US, UK, and Germany, a limited number of Japanese doctors are specialized in NP. Without sufficient numbers it is difficult to establish a specialist training system. Japanese neurology programs suffer from significant variability despite the creation of guidelines, in part due to small numbers of faculty in the university hospitals 88. Members of the JSN are currently discussing improvement of the specialist system of NP. Some neuropathologists in Japan believe that formal recognition of NP as a subspecialty of general pathology would improve the situation. Most academic neuropathologists are affiliated with neuroscience institutes, and are not always well associated with the Japanese Society of Pathology. In some cases, trainees return to clinical practice but continue to provide brain tumor pathology diagnoses because there is no law that limits doctors to specific areas of diagnostics in Japan.
China
In the early to mid‐1900s, the few practicing neuropathologists working in China had trained in Germany or England 52. The academic pursuits of neuropathologists were interrupted by political circumstances from 1967 to 1976. Thereafter, pathologists interested in brain diseases again began to train abroad and within China through local apprenticeships 133. In Hong Kong during the 1970s and 1980s, pathologists with aspirations to NP trained in the UK. The first Hong Kong College of Pathologists examination in NP was offered in 1997; however, the broader community of pathologists did not readily accept NP as a specialty discipline 87. Typically, postgraduate training in pathology had consisted of a 2‐ to 3‐year research‐oriented graduate degree followed by a 2‐ to 3‐year residency and transition into a faculty position without examination. This training was often poorly regulated 128. In 2012, a 3‐year standardized training curriculum for residents in clinical pathology was initiated (http://www.moh.gov.cn/zhuzhan/zqyj/201306/0216517e893a44a8bda852990d7128a7.shtml), but there is no formal NP residency (F. William Orr and Ho‐Keung Ng, pers. comm.). Currently in China, neurologists or pathologists with additional specialized NP training practice NP. Clinicopathological conferences are an important platform for education of young neuropathologists and special courses are offered by some hospitals and societies 135. Experience with brain tumors is considerable in China, particularly in the neurosurgical centers. The Neurology Branch of the Chinese Medical Association has numerous working groups, including ones devoted to NP, cerebrospinal fluid (CSF) cytology and neuromuscular disease 128. Unfortunately, the low rate of autopsies in China 134 and the relatively low research productivity in pathology 65 are two factors that could inhibit the training of neuropathologists as it is done in Europe and North America.
India
Following medical school, 3 years of training in AP and autopsy permits trainees to write the nationwide exam for Anatomic/Histopathology (Diplomate of National Board Examination in Pathology). In addition, many postgraduate medical colleges conduct their own examination after 3 years and award degrees. Unfortunately, there is a wide variation in the quality of pathology training across India 12. There is no formal recognition of NP in India and therefore few people have a true specialty practice. One wrote, “due to faulty policy and lack of job opportunities, the field of [diagnostic] neuropathology had a stunted growth” 22. Individuals working as neuropathologists in some of the large neurological centers typically had fellowship training abroad (especially the UK and Germany). Most have good diagnostic capability with respect to tumors and there are referral centers in New Delhi, Bangalore and Chandigarh. The National Institute of Mental Health and Neuro Sciences in Bangalore has had a Post Doctoral Fellowship in NP for ∼10 years. Training is not broad, however, because materials from suspected neurodegenerative and neurometabolic disorders are often sent abroad. For 10–15 years, there have been discussions about the formalization of training; however, given the small number of full‐time neuropathologists these efforts have not yet been fruitful (S.K. Shankar, pers. comm.).
Saudi Arabia
In the past decade, many individuals trained at North American NP centers have returned to Saudi Arabia. The RCPSC has worked extensively with the Saudi Commission on Health Specialties to facilitate the development of standards in postgraduate medical education including CanMEDS competencies for residency training in some large disciplines 91. The potential value of establishing NP training in Saudi Arabia was discussed recently 31. However, because of the paucity of autopsies, either training restricted to surgical NP or collaboration with other countries (where most of the neuropathologists in Saudi Arabia trained) would be necessary. There is no formal move toward this development (Hindi Al‐Hindi and Ali Assiri, pers. comm.).
South and Central America
In Brazil, NP is considered to be subspecialty of AP. The oversight body for the 3‐year AP residency is the Comissao Nacional de Residência Médica. Most neuropathologists in Brazil (∼15) are general or anatomic pathologists who became interested in NP and either went abroad for further training (typically 1–3 years), worked with experienced neuropathologists in Brazil, or got their own experience by examining or studying neuropathological cases. There is no formal examination or recognition of completed NP training (Leila Chimelli and Myriam Dumas Hahn, pers. comm.).
In Mexico, an official NP training program was approved by the National University of Mexico (UNAM) in 1990. Following 3 years of pathology training and certification by the Consejo Mexicano de Médicos Anatomopatólogos, residents may apply for the 2‐year NP residency program, offered only at the Hospital General de México. Three months of the training is spent in a different hospital, in Mexico or abroad. The theoretical and practical examination is validated through the UNAM. Currently, ∼13 neuropathologists in Mexico have the diploma issued by UNAM (Laura Chávez Macías, pers. comm.).
Discussion
Several important points and recurring themes can be appreciated from the above survey:
-
(i)
History and economics are important in the recognition of the NP discipline. Formalized training in NP occurs in countries with long histories of neuropathological research, especially those where an appreciation of autopsies spread from Europe in the late 1800s. The countries with codified training and defined oversight organizations are ones with greater wealth and greater per capita expenditures on health services, and not necessarily ones with large populations. With the exception of Poland, all countries that formally recognize NP as a medical specialty or subspecialty had annual per capita spending of >$US3500 (in 2010; see Table 1). The ratio of public to private expenditure on health did not correlate with the existence of formal training systems (eg, UK 84% public to US 53% public). Countries with high expenditures that do not have formal training systems are typically less populous European countries that participate in the Euro‐CNS. Some anomalies are apparent. Italy and Spain are populous and have per capita expenditures only slightly lower than that of the UK, but lack organized training. Japan is perhaps most surprising with considerable wealth, population and NP research, but no national training system. It seems that dedicated individuals willing to pressure the national organizations are the key to getting recognition. Following that, maintaining a credible quality oversight body is absolutely necessary.
-
(ii)
The recognition of NP as a specialty or subspecialty is important in some countries but not others. In jurisdictions where NP is recognized as a specialty, the underlying necessary body of knowledge is considered to overlap but be distinct from that used by anatomical pathologists. History shows that academic interests in autopsy NP arose from neurology and psychiatry in the late 1800s while brain tumor diagnostics were driven by neurosurgical needs in the early 1900s. Shared infrastructure provided the later impetus for convergence of NP and other facets of pathology. While it makes sense that most jurisdictions insist NP training take place only in centers with approved AP training programs, this does not inherently define NP as a subspecialty of AP. Contributors from many countries have noted the difficulty training and sustaining sufficient numbers of neuropathologists when lengthy training in AP is mandated prior to NP training. In these situations, national recognition as a specialty seems critical to solving the problem. The experiences in Canada are instructive; NP and AP were simultaneously identified as distinct specialties by the RCPSC in 1965, but when political expediency forced NP into a subspecialty status from 2003 to 2008 trainee enrollment plummeted.
This leads to the matter of predicting workloads and job opportunities. The training networks should be cognizant of the national needs for neuropathologists. Generation of too few, or inadequately trained, neuropathologists fail to meet societal needs. Generation of too many neuropathologists fail to meet needs of the “surplus” individuals. In 2012–2013, only 58% (42/72) of ACGME‐approved NP fellowship positions were filled 98. It is not clear if there are too few trainees or too many positions in the US. Detailed analyses in the US have been designed to predict pathology 98, neurology 21, 39 and neurosurgery 100 workforce needs; their validity remains uncertain. Survey data in Canada suggested that replacement neuropathologists would be needed to make up for two to three retirements per year 24. A NP workforce survey conducted by the CANP in 2011 suggested that one full‐time neuropathologist is needed for every ∼660 000 population in the current conditions of practice in Canada (Del Bigio et al, unpub. obs.).
Global economics and culture are undoubtedly important. In the countries described above, there is considerable variation in the job market. In Australia and the US, most of the positions advertised demand both AP and NP expertise; therefore, a pure NP specialty training stream is not necessary. Furthermore, in the US the mandated training for AP/NP is a reasonable 4–5 years. Developing countries that lack neurosurgeons to remove brain tumors 8 have little need for neuropathologists. Similarly, places where autopsies are rare for fiscal or cultural reasons have no need for neuropathologists to examine whole brains. Hence, spreading formal NP training worldwide is a rather unrealistic goal. The Outreach Program of the International Society of Neuropathology already recognizes that focused education rather than comprehensive training can benefit many regions 42. The minimum need of anatomical/surgical pathologists who provide service in neurosurgical centers is the ability to diagnose brain tumors according to the current WHO (World Health Organization) classification. This ability, however, does not make them neuropathologists. Although we are not far from inclusion of molecular and genetic details as a diagnostic adjunct 68, it will remain important to retain grounding in morphology to allow pathologists in disadvantaged regions to provide basic neuropathological diagnoses.
-
(iii)
Training content, duration, and organization demand national oversight. The mandated duration of training in core NP ranges from 2 to 4 years in the countries with formalized training. This ensures exposure to sufficient material and time to develop a knowledge, skill and experience base. An apparent exception is in Australasia where officially a 1‐year course leads to a diploma in NP; however, as described above the real training period typically approaches 2 years. Not surprisingly, where training curricula are defined, the content is almost identical with only minor variations across jurisdictions. Some demand categorical enumeration of cases studied while others only demand that competency can be achieved through active participation in evaluation of current specimens. It should be noted that excessive reliance on archival material is suboptimal. Some countries set the minimum number of teaching neuropathologists at each site. Although two may be allowable, most centers have more and it can be argued that three or more mentors are desirable in order to provide a varied learning experience (rather than an apprenticeship) and to ensure that the sometimes onerous training regulations can be met. An opportunity for exposure to rare entities through courses or external rotations at larger or specialized facilities is necessary to ensure comprehensive training. At local, national and supranational levels, a cadre of dedicated individuals are needed to avoid stagnancy in the system. Sharing of resources by training centers helps standardize training and make up for local deficiencies, for example, through development of practice examinations such as the Neuropathology fellow In‐Service Examination (NPISE) 97 or web‐based lecture series (eg, developed by Julia Keith in Canada). Online education is becoming more and more popular in many fields of study 59, 107; there is no reason why the international NP community could not develop useful educational tools.
-
(iv)
Competency‐based training is evolving. In the mid‐1990s, the principle of competency‐based medical training was envisaged and has since gained wide acceptance 70. National organizations have defined their core competencies slightly differently, but they are conceptual equals. CanMEDS, adopted by the RCPSC in 1996, defines the core competency as medical expert, with contributing competencies of scholar, professional, communicator, collaborator, manager and health advocate 1, 38. The ACGME in 1999 defined six general competency domains as patient care, medical knowledge, practice‐based learning and improvement, interpersonal and communication skills, professionalism, and systems‐based practice 116. The GMC (UK) describes seven competences including good clinical care, maintaining good medical practice, relationships with patients, working with colleagues, teaching and training, probity, and health. General and NP‐specific competencies across jurisdictions have remarkable similarities whether systems were created in parallel or adapted. One of the key features is ongoing and specific evaluation of each of the competencies during training. Most agree that the concept is sound, but implementation has not been entirely easy for a variety of reasons, among them the time required to meet the administrative demands and the difficulty evaluating some of the competencies 2, 36. Many have criticized that the psychometric tools used to assess competencies are inadequate 44, 71 and that the guidance is vague 35. Medical education developers and administrators must develop systems that are practical, and avoid jargon that serves to confuse the users (both teachers/evaluators and trainees/learners). A survey of anesthesia program directors in the US indicated that the greatest source of stress arose from ACGME documentation and compliance matters 23.
The most important benefit of the educational formalities has been the standardization of NP training objectives 19. A (hopefully) positive step will be the development of “milestones,” which have been defined in the context of education as discreet observable behaviors that characterize each proficiency. In effect, steps needed to acquire the competencies are identified clearly 14. With conscientious design, milestones may be a means for predicting competence for independent practice 80. The Pathology Milestone Project is currently being developed in the US by the ACGME and the ABP and will soon be mapped onto NP training with implementation targeted for 2014 84.
Trainee selection is a facet of medical education that must also be considered. Is it possible to identify attributes that will enhance competencies in NP? There are no objective studies specifically on the subject. In Canada, neuropathologists who are academically productive are more likely to have had prior formal research training in a neuroscience field 24. It is likely that this contributed to career selection. A few studies relate to selection of candidates for histopathology (AP) training. The author of a comprehensive review concluded, “there are insufficient data to justify the compulsory use of aptitude tests to select suitable candidates for histopathology training, although the employment of standard test of visuospatial reasoning and memory would probably act as satisfactory surrogate measures” 20. Structured interviews at a central location were used for histopathology candidates in the UK in 2009. The details of the interview process, and the advantages and disadvantages of the centralized matching of candidates and training centers have been published 57, 117. In the US, many NP fellowships are outside of the central match 11. In a 2006 survey, US pathology program directors perceived most important criteria for trainee selection to be: recommendation letters, “grades” in related electives and United States Medical Licensing Examination (USMLE) scores 43. However, there is no objective evidence that USMLE step 1 and 2 scores predict performance in clinical medicine residencies and their use for “selection decisions is discouraged” 75. A recent meta‐analysis was conducted to determine selection strategies associated with future resident and doctor performance (in any discipline). The authors concluded that examination‐based selection strategies are more predictive than subjective selection strategies (eg, reference letters). The subjective strategy with the strongest predictive value was the consensus committee ranking, which is a synthesis of many factors 60.
-
(v)
The teachers must learn and change. As discussed above, training guidelines are typically developed in larger disciplines under test situations and then imposed broadly upon postgraduate medical educators including neuropathologists. NP, being a very small medical discipline, has little influence on the oversight agencies, so it is best to work with them constructively. In 1965, Martin Netsky, then president of the AANP, wrote, “we should be interested in experimenting scientifically with new methods of teaching. … The cardinal question should be, how does each student learn best?” He also wrote, “when second‐rate research is rewarded more than first‐rate teaching, … , when publications and often only their proliferation become the measure of value, then something is wrong” 85. We should embrace his advice. Changes in the training of future medical specialists are demanded by changes in the practice of academic medicine, changing expectations of trainees, changes in information technologies, and the need to balance the art and science of the profession 32. Leaders of some large disciplines hold the opinion that formal education training is an asset for residency program directors 121, although this may not be practical in a small discipline like NP.
-
(vi)
Future expectations. The main tool of the diagnostic neuropathologist is the light microscope. However, this is gradually changing with the inclusion of molecular criteria into brain tumor diagnostics 68 and genetic sequencing especially for neurodegenerative and neuromuscular disease 127. The time may come when excisional biopsies and autopsies play a role in the context of imaging, spectroscopy, genetic, proteomic and lipidomic analyses. Beyond histopathology training, we must ensure that prospective neuropathologists are capable of integrating new and complementary diagnostic information, for example, as a guide for personalized medical therapy.
There is a critical need for imparting a never‐ending desire to learn and innovate 69, 122. Perhaps a greater focus on the value of research could do this. In 1960, Alfred Meyer reminded readers of the importance of fundamental advancements, suggesting that neuropathologists should acquire training in the basic translational and clinical sciences or be amenable to participation in a team 82. Many neuropathologists have formal research training prior to or concurrent with their clinical training. Surveys showed that 66% of Canadian neuropathologists have a graduate (MSc or PhD) degree 24; in 2010, 55% of AANP members had protected time for research 17. Gonatas suggested in 1982 that trainees seriously interested in combined diagnostic NP and research careers should take a minimum of 3 years in the basic translational or clinical sciences 129. More recent evidence indicates that formal clinician investigator training, with 2–3 years of mentored research during the residency or fellowship, generates academically successful personnel 29, 58. However, it remains unclear what research should be expected of the “regular” neuropathologist trainee. In 1954, Lester King opined, “The period of special training must avoid like the plague any thought of ‘writing a paper’. This besetting sin, that a young man who tries to learn something must also see his name in print, is the curse of modern education” 62. This was not a widely held opinion then, nor is it today. There are several good reasons to involve trainees in research: to improve the quality of medical care, to improve trainees' understanding of the medical and scientific literature by contributing to it, and to attract future academicians 47, 92. A longitudinal study of internal medicine trainees showed those who published during residency were more likely to continue publishing after residency 96. In the right setting, diagnostic NP duties and tissue‐based research may be of substantial mutual benefit 45. To facilitate research projects, several factors must be possible: trainee interest, available time for trainee, good mentors with adequate time to devote to the project, a curriculum for development of research skills, a formal resident project proposal review process, funding for the work and support for presentation at national or international conferences 130 101.
At the very least, NP trainees should realize that enormous opportunities remain for research into brain function and disease. The NP discipline has benefitted from research endeavors that arose from the Human Genome Project and Decade of the Brain initiatives in the 1990s. Now we look forward to the Human Brain Project, the Human Connectome Project 126 and the BRAIN Initiative 53. Although primarily driven by imaging technologies, detailed morphologic studies are necessary to understand the noninvasive imaging. When in the next decade the technologies move to the level of human brain investigation, neuropathologists should be in a position to contribute. Perhaps there will even be a convergence of NP and psychiatry and healing of a schism that occurred a century ago for lack of the tools to detect abnormalities in the brains of persons with psychiatric illnesses 67. As noted in an essay in The Economist, “Doctors have found it convenient to distinguish between disorders of the mind … which leave no obvious anatomical trace, and disorders of the brain … which do. But this is surely a false distinction; it is merely that the anatomical traces of psychiatric disorders have not yet been found” 5. The next generation of neuropathologists should be on the forefront of these discoveries.
Acknowledgments
Marc Del Bigio chairs the Specialty Committee on Neuropathology for the Royal College of Physicians and Surgeons of Canada, and holds the Canada Research Chair in Developmental Neuropathology. Johannes Hainfellner serves at the Medical University of Vienna as Interim Director of the Institute of Neurology, as coordinator of the PhD Program Clinical Neurosciences (CLINS) and as coordinator of the MedUni Vienna Neurobiobank. JAH serves also as Chair of the Specialty Committee on Neuropathology for the Austrian Medical Chamber, serves as Editor‐in‐Chief of Clinical Neuropathology (the official publication of Euro‐CNS) and as Euro‐CNS vice president. Catriona McLean is Chair of the Pathology Board of Education at Monash University and director of the Australian Brain Bank Network. Suzanne Powell is Chair of the neuropathology fellowship program directors group at the AANP, Chair of the Residency Review Committee for Pathology of the ACGME, and Chair of the Residency Program Directors Section (PRODS) of the Association of Pathology Chairs. Hitoshi Takahashi is President of the Japanese Society of Neuropathology. John Xuereb chairs the Euro‐CNS Examination Board. Joachim Weis is director of the Institute of Neuropathology, Aachen University, Germany, President of Euro‐CNS, and Past‐President of the DGNN.
References
- 1. CanMEDS 2000 (2000) Extract from the CanMEDS 2000 Project Societal Needs Working Group Report. Med Teach 22:549–554. [DOI] [PubMed] [Google Scholar]
- 2. Alexander CB (2006) Pathology graduate medical education (overview from 1926 to 2005). Hum Pathol 37:923–928. [DOI] [PubMed] [Google Scholar]
- 3. Allen IV (2006) The changing face of neuropathology. In: Understanding Disease: A Centenary Celebration of the Pathological Society. Hall PA, Wright NA (eds), Chapter 16, pp. 185–191. John Wiley & Sons: Hoboken NJ. [Google Scholar]
- 4. American Board of Pathology. Available at: http://www.abpath.org/BofISubspecialtyCert.htm (accessed 30 November 2013).
- 5.Anonymous (2013) Only connect. The Economist 406:75–76. [Google Scholar]
- 6. Arendt A (1979) Entwicklung der Neuropathologie. Zentralbl Allg Pathol 123:444–447. [PubMed] [Google Scholar]
- 7. Arendt A (1983) Die Rolle der Neuropathologie in der Allgemeinen Pathologie und Speziellen Pathologischen Anatomie. Zentralbl Neurochir 44:113–120. [PubMed] [Google Scholar]
- 8. Ausman JI (1997) What is happening in neurosurgery around the world? Surg Neurol 47:205–208. [DOI] [PubMed] [Google Scholar]
- 9. Bailey OT (1964) Observations on the Development of Neuropathology in the United States. Proc Inst Med Chic 25:154–158. [PubMed] [Google Scholar]
- 10. Bailey P, Cushing H (1926) A Classification of the Tumors of the Glioma Group on a Histogenetic Basis with a Correlated Study of Prognosis. J. B. Lippincott Co.: Philadelphia PA. [Google Scholar]
- 11. Bernacki KD, McKenna BJ, Myers JL (2012) Challenges and opportunities in the application process for fellowship training in pathology: an independent survey of residents and fellows demonstrates limited interest in an NRMP‐style matching program. Am J Clin Pathol 137:543–552. [DOI] [PubMed] [Google Scholar]
- 12. Bhusnurmath SR, Bhusnurmath BS (2011) How can the postgraduate training program in pathology departments in India be improved? Indian J Pathol Microbiol 54:441–447. [DOI] [PubMed] [Google Scholar]
- 13. Bundesärztekammer (2012) Article VI‐102.
- 14. Carraccio C, Burke AE (2010) Beyond competencies and milestones: adding meaning through context. J Grad Med Educ 2:419–422. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Clarac F, Barbara JG, Broussolle E, Poirier J (2012) Figures and institutions of the neurological sciences in Paris from 1800 to 1950. Introduction and Part I: neuroanatomy. Rev Neurol (Paris) 168:2–14. [DOI] [PubMed] [Google Scholar]
- 16. Clarac F, Boller F (2010) History of neurology in France. Handb Clin Neurol 95:629–656. [DOI] [PubMed] [Google Scholar]
- 17. Cochran EJ (2010) AANP Workforce Survey, American Association of Neuropathologists: Madison WI.
- 18. Corvisier‐Visy N, Poirier J (1996) La neuropathologie en France (XIXe‐XXe siecles) avatars semantiques et institutionnels. Arch Anat Cytol Pathol 44:18–27. [PubMed] [Google Scholar]
- 19. Crain BJ, Alston SR, Bruch LA, Hamilton RL, McLendon RE, Rhodes CH et al (2005) Accreditation council for graduate medical education (ACGME) competencies in neuropathology training. J Neuropathol Exp Neurol 64:273–279. [DOI] [PubMed] [Google Scholar]
- 20. Cross SS (2005) Aptitude testing and assessment of training progress in histopathology. Curr Diagn Pathol 11:299–307. [Google Scholar]
- 21. Dall TM, Storm MV, Chakrabarti R, Drogan O, Keran CM, Donofrio PD et al (2013) Supply and demand analysis of the current and future US neurology workforce. Neurology 81:470–478. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Das S, Shankar SK (2009) Neuropathology. In: Neurosciences in India. Dhawan BN, Seth PK (eds), pp. 175–232. Indian Academy of Neurosciences & Council of Scientific and Industrial Research: New Delhi. [Google Scholar]
- 23. De Oliveira GS Jr, Almeida MD, Ahmad S, Fitzgerald PC, McCarthy RJ (2011) Anesthesiology residency program director burnout. J Clin Anesth 23:176–182. [DOI] [PubMed] [Google Scholar]
- 24. Del Bigio MR, Johnson ES (2010) Neuropathology in Canada: overview of development and current status. Can J Neurol Sci 37:206–212. [DOI] [PubMed] [Google Scholar]
- 25. Del Bigio MR, Rewcastle NB (2010) Neuropathology in Canada: the first one hundred years. Can J Neurol Sci 37:725–744. [DOI] [PubMed] [Google Scholar]
- 26. Dhom G (1997) 100 Jahre Deutsche Gesellschaft fur Pathologie (1897–1997). Pathologe 18:S1–S17. [DOI] [PubMed] [Google Scholar]
- 27. Dodgson MC (1973) Why are there so few neuropathologists in Australia? Med J Aust 2:618. [DOI] [PubMed] [Google Scholar]
- 28. Dodgson MC (1973) Why are there so few neuropathologists in Australia? Med J Aust 1:1316–1317. [DOI] [PubMed] [Google Scholar]
- 29. Dyrbye LN, Lindor KD, LaRusso NF, Cook DA (2008) Research productivity of graduates from 3 physician‐scientist training programs. Am J Med 121:1107–1113. [DOI] [PubMed] [Google Scholar]
- 30. Earle KM (1993) “Nature reveals herself to science”. Memoirs of Kenneth Martin Earle, M.D., M.Sc. J Neuropathol Exp Neurol 52:174–180. [DOI] [PubMed] [Google Scholar]
- 31. Editorial Team Euro‐CNS News (2011) Neuropathology as a new specialty in the Kingdom of Saudi Arabia—an interview with Manuel Graeber. Clin Neuropathol 30:158–160. [Google Scholar]
- 32. Elkind MS (2009) Teaching the next generation of neurologists. Neurology 72:657–663. [DOI] [PubMed] [Google Scholar]
- 33. Feindel W (2003) Osler and the “medico‐chirurgical neurologists”: Horsley, Cushing, and Penfield. J Neurosurg 99:188–199. [DOI] [PubMed] [Google Scholar]
- 34. Ferraro A (1954) Relationship of neuropathology to neurology, psychiatry and pathology. J Neuropathol Exp Neurol 13:509–514. [DOI] [PubMed] [Google Scholar]
- 35. Feske S (2009) ACGME, test thyself! Neurology 72:302–303. [DOI] [PubMed] [Google Scholar]
- 36. Folberg R, Antonioli DA, Alexander CB (2002) Competency‐based residency training in pathology: challenges and opportunities. Hum Pathol 33:3–6. [DOI] [PubMed] [Google Scholar]
- 37. Foley PB, Storey CE (2010) History of neurology in Australia and New Zealand. Handb Clin Neurol 95:781–800. [DOI] [PubMed] [Google Scholar]
- 38. Frank JR, Danoff D (2007) The CanMEDS initiative: implementing an outcomes‐based framework of physician competencies. Med Teach 29:642–647. [DOI] [PubMed] [Google Scholar]
- 39. Freeman WD, Vatz KA, Griggs RC, Pedley T (2013) The Workforce Task Force Report: Clinical implications for neurology. Neurology 81:479–486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Geddes J (2001) From treponemes to prions: the emergence of British Neuropathology. In: Twentieth Centrury Neurology the British Contribution. Rose FC (ed.), Chapter 18, pp. 227–254. Imperial College Press: London UK. [Google Scholar]
- 41. Goedert M, Ghetti B (2007) Alois Alzheimer: his life and times. Brain Pathol 17:57–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Graham DI (2002) International Society of Neuropathology Outreach Program. Brain Pathol 12:260–262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Green M, Jones P, Thomas JX Jr (2009) Selection criteria for residency: results of a national program directors survey. Acad Med 84:362–367. [DOI] [PubMed] [Google Scholar]
- 44. Green ML, Holmboe E (2010) Perspective: the ACGME toolbox: half empty or half full? Acad Med 85:787–790. [DOI] [PubMed] [Google Scholar]
- 45. Hainfellner JA, Heinzl H (2010) Neuropathological biomarker candidates in brain tumors: key issues for translational efficiency. Clin Neuropathol 29:41–54. [DOI] [PubMed] [Google Scholar]
- 46. Hakosalo H (2006) The brain under the knife: serial sectioning and the development of late nineteenth‐century neuroanatomy. Stud Hist Philos Biol Biomed Sci 37:172–202. [DOI] [PubMed] [Google Scholar]
- 47. Hamann KL, Fancher TL, Saint S, Henderson MC (2006) Clinical research during internal medicine residency: a practical guide. Am J Med 119:277–283. [DOI] [PubMed] [Google Scholar]
- 48. Hassin GB (1942) The rise of neuropathology. J Neuropathol Exp Neurol 1:1–2. [Google Scholar]
- 49. Hassin GB (1950) Neuropathology, an historical sketch. J Neuropathol Exp Neurol 9:1–17. [DOI] [PubMed] [Google Scholar]
- 50. Henry JM (1998) Neurons and Nobel Prizes: a centennial history of neuropathology. Neurosurgery 42:143–155. [DOI] [PubMed] [Google Scholar]
- 51. Hilliard ET (1975) Dr. Oliver Latham. Aust N Z J Psychiatry 9:120. [PubMed] [Google Scholar]
- 52. Huang KW (1991) Neuropathology in the People's Republic of China—a personal perspective. Brain Pathol 1:217–218. [PubMed] [Google Scholar]
- 53. Insel TR, Landis SC, Collins FS (2013) Research priorities. The NIH BRAIN Initiative. Science 340:687–688. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Jargin SV (2013) Some aspects of medical education in Russia. Am J Med Stud 1:4–7. [Google Scholar]
- 55. Jellinger KA (2006) Highlights in the history of neurosciences in Austria—review. Clin Neuropathol 25:243–252. [PubMed] [Google Scholar]
- 56. Jellinger KA (2006) A short history of neurosciences in Austria. J Neural Transm 113:271–282. [DOI] [PubMed] [Google Scholar]
- 57. Johnston PW, French FH (2008) Analysis of selection tools for appointment of specialty trainees in histopathology in Scotland. Br J Hosp Med (Lond) 69:101–105. [DOI] [PubMed] [Google Scholar]
- 58. Kearney RA, Lee SY, Skakun EN, Tyrrell DL (2007) The research productivity of Canadian physicians: how the timing of obtaining a PhD has an influence. Acad Med 82:310–315. [DOI] [PubMed] [Google Scholar]
- 59. Kellogg S (2013) Online learning: how to make a MOOC. Nature 499:369–371. [DOI] [PubMed] [Google Scholar]
- 60. Kenny S, McInnes M, Singh V (2013) Associations between residency selection strategies and doctor performance: a meta‐analysis. Med Educ 47:790–800. [DOI] [PubMed] [Google Scholar]
- 61. Kepes JJ, Burger PC (1982) Surgical pathology and neuropathology: two viewpoints. J Neuropathol Exp Neurol 41:1–5. [DOI] [PubMed] [Google Scholar]
- 62. King LS (1954) Training in Neuropathology. II. Lab Invest 3:405–409. [PubMed] [Google Scholar]
- 63. Kozu T (2006) Medical education in Japan. Acad Med 81:1069–1075. [DOI] [PubMed] [Google Scholar]
- 64. Kreft G, Kovacs GG, Voigtlander T, Haberler C, Hainfellner JA, Bernheimer H, Budka H (2008) 125th anniversary of the Institute of Neurology (Obersteiner Institute) in Vienna. “Germ Cell” of interdisciplinary neuroscience. Clin Neuropathol 27:439–443. [DOI] [PubMed] [Google Scholar]
- 65. Li Z, Wan X, Lu A, Li X, Li J (2010) Pathological research output in China and other top‐ranking countries: 10‐year survey of the literature. Pathol Res Pract 206:835–838. [DOI] [PubMed] [Google Scholar]
- 66. Lichterman B (2010) A history of Russian and Soviet neuro(patho)logy. Handb Clin Neurol 95:737–754. [DOI] [PubMed] [Google Scholar]
- 67. Lishman WA (1995) Psychiatry and neuropathology: the maturing of a relationship. J Neurol Neurosurg Psychiatry 58:284–292. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Louis DN (2012) The next step in brain tumor classification: “Let us now praise famous men” … or molecules? Acta Neuropathol 124:761–762. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69. Louis DN, Virgin HW, Asa SL (2011) “Next‐generation” pathology and laboratory medicine. Arch Pathol Lab Med 135:1531–1532. [DOI] [PubMed] [Google Scholar]
- 70. Lurie SJ (2012) History and practice of competency‐based assessment. Med Educ 46:49–57. [DOI] [PubMed] [Google Scholar]
- 71. Lurie SJ, Mooney CJ, Lyness JM (2009) Measurement of the general competencies of the accreditation council for graduate medical education: a systematic review. Acad Med 84:301–309. [DOI] [PubMed] [Google Scholar]
- 72. Macchi G (1981) A brief comment on the present and future of neuropathology in Italy. Ital J Neurol Sci 2:109–110. [DOI] [PubMed] [Google Scholar]
- 73. Markram H, Meier K, Ailamaki A, Alvandpour A, Amunts K, Andreoni W et al (2012) The Human Brain Project. A report to the European Commission. Available at: http://www.humanbrainproject.eu/ (accessed 20 November 2013), The HBP‐PS Consortium: Lausanne.
- 74. Matsushita M (2000) History of neuropathology in Japan. Neuropathology 20:S2–S6. [DOI] [PubMed] [Google Scholar]
- 75. McGaghie WC, Cohen ER, Wayne DB (2011) Are United States Medical Licensing Exam Step 1 and 2 scores valid measures for postgraduate medical residency selection decisions? Acad Med 86:48–52. [DOI] [PubMed] [Google Scholar]
- 76. McMenemey WH (1953) Santiago Ramon y Cajal; 1852–1934. Proc R Soc Med 46:173–178. [PMC free article] [PubMed] [Google Scholar]
- 77. McMenemey WH (1958) The future position of the pathologist in medicine. Lancet 2:841–844. [DOI] [PubMed] [Google Scholar]
- 78. McMenemey WH (1959) Neuropathology in Western Europe: part II Great Britain. J Neuropathol Exp Neurol 18:645–647. [Google Scholar]
- 79. McMenemey WH (1965) The practice of neuropathology. Past, present and future. Lancet 2:1337–1340. [PubMed] [Google Scholar]
- 80. Meade LB, Borden SH, McArdle P, Rosenblum MJ, Picchioni MS, Hinchey KT (2012) From theory to actual practice: creation and application of milestones in an internal medicine residency program, 2004–2010. Med Teach 34:717–723. [DOI] [PubMed] [Google Scholar]
- 81. Mennel HD (1991) Grading of intracranial tumors following the WHO classification. Neurosurg Rev 14:249–260. [DOI] [PubMed] [Google Scholar]
- 82. Meyer A (1960) Some recent trends in neuropathology. J Mental Sci 106:1181–1194. [Google Scholar]
- 83. Mikol J, Weller R (2006) Neuropathology in Europe: an overview. Clin Neuropathol 25:7–13. [PubMed] [Google Scholar]
- 84. Nasca TJ, Philibert I, Brigham T, Flynn TC (2012) The next GME accreditation system–rationale and benefits. N Engl J Med 366:1051–1056. [DOI] [PubMed] [Google Scholar]
- 85. Netsky MG (1965) Presidential Address. The Medical Profession and Neuropathology. J Neuropathol Exp Neurol 24:1–10. [DOI] [PubMed] [Google Scholar]
- 86. Netsky MG (1976) Training programs in neuropathology: a study and an inquiry into distribution of neuropathologists. J Neuropathol Exp Neurol 35:520–531. [DOI] [PubMed] [Google Scholar]
- 87. Ng HK (1999) Neuropathology. In: Hong Kong Neurosurgery: Four Decades & Beyond. Poon WS (ed.), Chapter 2, pp. 8–17. Hong Kong Neurosurgical Society: Hong Kong. [Google Scholar]
- 88. Nodera H (2009) International issues: postgraduate neurologic training in Japan. Neurology 72:e34–e36. [DOI] [PubMed] [Google Scholar]
- 89. Nonomura A, Minato H, Koike M (2002) Postgraduate medical training in anatomical pathology in Japanese national universities. Rinsho Byori 50:347–352. [PubMed] [Google Scholar]
- 90. Osetowska E (1969) Development of neuropathology in People's Poland. Neuropatol Pol 7:213–216. [PubMed] [Google Scholar]
- 91. Padmos A (2012) A long message on Royal College international activities. In: Message from the CEO. Royal College of Physicians and Surgeons of Canada: Ottawa ON. [Google Scholar]
- 92. Peerschke EI, Agrawal Y, Alexander CB, Bovill E, Laposata M (2007) Proposed research training guidelines for residents in laboratory medicine. Clin Lab Med 27:241–253. [DOI] [PubMed] [Google Scholar]
- 93. Peiffer J (1979) Zur Situation der Neuropathologie in der Bundesrepublik Deutschland 1979. Pathol Res Pract 165:445–457. [DOI] [PubMed] [Google Scholar]
- 94. Peiffer J (1997) 100 Jahre deutsche Neuropathologie. Pathologe 18(Suppl. 1):S21–S32. [DOI] [PubMed] [Google Scholar]
- 95. Plaut A (1953) Rudolf Virchow and today's physicians and scientists. Bull Hist Med 27:236–251. [PubMed] [Google Scholar]
- 96. Prasad V, Rho J, Selvaraj S, Toomey C, Vandross A, Ho N (2012) Publication trends among internal medicine residents and graduates. Am J Med 125:939–944. [DOI] [PubMed] [Google Scholar]
- 97. Rinder HM, Grimes MM, Wagner J, Bennett BD (2011) Senior pathology resident in‐service examination scores correlate with outcomes of the American Board of Pathology certifying examinations. Am J Clin Pathol 136:499–506. [DOI] [PubMed] [Google Scholar]
- 98. Robboy SJ, Weintraub S, Horvath AE, Jensen BW, Alexander CB, Fody EP et al (2013) Pathologist Workforce in the United States: I. Development of a Predictive Model to Examine Factors Influencing Supply. Arch Pathol Lab Med 137:1723–1732. [DOI] [PubMed] [Google Scholar]
- 99. Roizin L (1957) Essay on the origin and evolution of neuropathology; some fundamental neuropathologic contributions to psychiatry. Psychiatr Q 31:531–555. [DOI] [PubMed] [Google Scholar]
- 100. Rosman J, Slane S, Dery B, Vogelbaum MA, Cohen‐Gadol AA, Couldwell WT (2013) Is there a shortage of neurosurgeons in the United States? Neurosurgery 73:354–366. [DOI] [PubMed] [Google Scholar]
- 101. Rothberg MB (2012) Overcoming the obstacles to research during residency: what does it take? JAMA 308:2191–2192. [DOI] [PubMed] [Google Scholar]
- 102. Royal College of Physicians and Surgeons of Canada (2007) 2nd Meeting of the Working Group in Laboratory Medicine [WGLM]. Ottawa ON.
- 103. Ruiter DJ, Roald B, Underwood J, Prat J (2004) Histopathology training in Europe: a lesson for other specialties? Virchows Arch 444:278–282. [DOI] [PubMed] [Google Scholar]
- 104. Safavi‐Abbasi S, Reis C, Talley MC, Theodore N, Nakaji P, Spetzler RF, Preul MC (2006) Rudolf Ludwig Karl Virchow: pathologist, physician, anthropologist, and politician. Implications of his work for the understanding of cerebrovascular pathology and stroke. Neurosurg Focus 20:E1–E6. [DOI] [PubMed] [Google Scholar]
- 105. Schiffer D (2010) The history of neuropathology in Italy. Clin Neuropathol 29:177–181. [DOI] [PubMed] [Google Scholar]
- 106. Schröder JM (2010) Optimal conditions for the recognition of neuropathology as a medical specialty 1985 in Germany. Clin Neuropathol 29:56. [Google Scholar]
- 107. Searls DB (2012) Ten simple rules for online learning. PLoS Comput Biol 8:e1002631. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108. Seitelberger F (1956) Zweck und Ziele der Oesterreichischen Arbeitsgemeinschaft fur Neuropathologie. Wien Med Wochenschr 106:980–981. [PubMed] [Google Scholar]
- 109. Seitelberger F (1993) Die Neuropathologie in den Neurowissenschaften. Ein System im Wandel. Nervenarzt 64:524–529. [PubMed] [Google Scholar]
- 110. Simpson DA, Jamieson KG, Morson SM (1974) The foundations of neurosurgery in Australia and New Zealand. Aust N Z J Surg 44:215–227. [DOI] [PubMed] [Google Scholar]
- 111. Smith MC (1968) Distribution of neuropathologists in relation to neurologists and neurosurgeons. Proc R Soc Med 61:1010–1016. [PMC free article] [PubMed] [Google Scholar]
- 112. Smith WT (1974) A Legacy from the Blighted Brain. University of Birminham: Birmingham UK. [Google Scholar]
- 113. Somjen GG (1988) Nervenkitt: notes on the history of the concept of neuroglia. Glia 1:2–9. [DOI] [PubMed] [Google Scholar]
- 114. Strösser W (1993) Deutsche Gesellschaft für Neuropathologie und Neuroanatomie e.V. 1950–1992. Eine Untersuchung zur Entwicklung der Gesellschaft und zur Förderung des Faches Neuropathologie in Deutschland., German Society of Neuropathology and Neuroanatomy: Berlin.
- 115. Struhal W, Sellner J, Lisnic V, Vecsei L, Muller E, Grisold W (2011) Neurology residency training in Europe—the current situation. Eur J Neurol 18:e36–e40. [DOI] [PubMed] [Google Scholar]
- 116. Swing SR (2007) The ACGME outcome project: retrospective and prospective. Med Teach 29:648–654. [DOI] [PubMed] [Google Scholar]
- 117. Thomas H, Taylor CA, Davison I, Field S, Gee H, Grant J et al (2012) National Evaluation of Specialty Selection: Final Report. August 2010, University of Birmingham: Birmingham UK.
- 118. Tighe RJ (1987) British postgraduate training in pathology. J Clin Pathol 40:940–947. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119. Totsch M, Cuvelier C, Vass L, Fassina A (2012) The UEMS section/board of pathology, chapter 6: requirement for recognition of postgraduate training in pathology: a presentation of the Paris document. Cytopathology 23:295–299. [DOI] [PubMed] [Google Scholar]
- 120. Totsch M, Vass L, Fassina A (2011) The UEMS training charter for pathology: a common trunk and a challenge ahead for the EFCS. Cytopathology 22:349–351. [DOI] [PubMed] [Google Scholar]
- 121. Turner TL, Ward MA, Palazzi DL, Lorin MI (2011) Value placed on formal training in education by pediatric department chairs and residency program directors. J Grad Med Educ 3:558–561. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122. Uchihara T (2011) Expanding morphological dimensions in neuropathology, from sequence biology to pathological sequences and clinical consequences. Neuropathology 31:201–207. [DOI] [PubMed] [Google Scholar]
- 123. Underwood JCE (2006) A short history of the Royal College of Pathologists. In: Understanding Disease: A Centenary Celebration of the Pathological Society. Hall PA, Wright NA (eds), Chapter 11, pp. 129–135. John Wiley & Sons: Hoboken NJ. [Google Scholar]
- 124. Valk N, Haslam RH (2004) Recover neuropathology. Can J Neurol Sci 31:140–141. [DOI] [PubMed] [Google Scholar]
- 125. van den Tweel JG (2007) Pathology sans frontiers. J Clin Pathol 60:456–457. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 126. Van Essen DC, Ugurbil K, Auerbach E, Barch D, Behrens TE, Bucholz R et al (2012) The Human Connectome Project: a data acquisition perspective. Neuroimage 62:2222–2231. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 127. Vasli N, Bohm J, Le Gras S, Muller J, Pizot C, Jost B et al (2012) Next generation sequencing for molecular diagnosis of neuromuscular diseases. Acta Neuropathol 124:273–283. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 128. Wang XP, Zhang WF, Huang HY, Preter M (2010) Neurology in the People's Republic of China—an update. Eur Neurol 64:320–324. [DOI] [PubMed] [Google Scholar]
- 129. Webster HD, Gonatas NK (1982) Research and research training in neuropathology—two viewpoints. Research in neuropathology. J Neuropathol Exp Neurol 41:247–252. [DOI] [PubMed] [Google Scholar]
- 130. West CP, Halvorsen AJ, McDonald FS (2011) Scholarship during residency training: a controlled comparison study. Am J Med 124:983–987. [DOI] [PubMed] [Google Scholar]
- 131. Wolf A (1954) Training in neuropathology. I. Lab Invest 3:402–405. [PubMed] [Google Scholar]
- 132. Wolf A (1964) Careers in neuropathology. Lab Invest 13:652–657. [PubMed] [Google Scholar]
- 133. Zhang WW, Lu DH (2008) Neuropathology in China. Neuropathol Appl Neurobiol 34:373–374. [DOI] [PubMed] [Google Scholar]
- 134. Zhu MH, Yu DH (2011) Fluctuations in the rate of autopsy in China. Chin Med J (Engl) 124:3403–3407. [PubMed] [Google Scholar]
- 135. Zhu MW, Liu J, Wang LN, Lu DH (2013) Development of clinical neuropathology in China during the past half century: a publication survey. J Neuropathol Exp Neurol 72:892–894. [DOI] [PubMed] [Google Scholar]
- 136. Zimmerman HM (1964) Discussion. Lab Invest 13:655–657. [Google Scholar]
- 137. Zubritsky AN (2008) Russian centre of pathology as a basis of progress of Russian pathology in the future. Acta Med Bulg 35:69–73. [Google Scholar]